	Le Coût Des Ventes		Date
Agios Pharmaceuticals	USD 1.88M	199K	2025-12
Alnylam Pharmaceuticals	USD 267.72M	67.57M	2025-12
Amgen	USD 1.79B	128M	2025-12
Biogen	USD 810.1M	205.1M	2025-09
BioMarin Pharmaceutical	USD 161.56M	16.62M	2025-12
Daiichi Sankyo	JPY 118.28B	37.7B	2025-12
Esperion Therapeutics	USD 51.63M	22.2M	2024-09
Exelixis	USD 26.48M	7.91M	2025-12
Gilead Sciences	USD 1.62B	50M	2025-12
Glaxosmithkline	GBP 3.01B	853.01M	2025-09
Incyte	USD 121.18M	22.18M	2025-12
MacroGenics	USD 44.3M	5.4M	2025-09
Moderna	USD 452M	245M	2025-12
Novartis	USD 3.54B	217M	2025-09
Pfizer	USD 6.29B	2.12B	2025-12
PTC Therapeutics	USD 16.3M	7.02M	2025-12
Puma Biotechnology	USD 29.1M	18.44M	2024-09
Regeneron Pharmaceuticals	USD 584.6M	63M	2025-12
Roche Holding	CHF 8.48B	4.61B	2025-12
Sangamo BioSciences	2.42M	1.11M	2024-06
Sarepta Therapeutics	USD 399.38M	247.93M	2025-12
Takeda	JPY 401.15B	184.07B	2025-12
TG Therapeutics	USD 38.14M	10.05M	2025-12
Ultragenyx Pharmaceutical	USD 29M	1.01M	2025-12
Vanda Pharmaceuticals	USD 198.77M	151.12M	2024-12
Vertex Pharmaceuticals	USD 466M	51.2M	2025-12

Puma Biotechnology Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.